Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

viatris limited - methyldopa sesquihydrate 141.5mg equivalent to to 125 mg methyldopa anhydrous - tablet - 125 mg - active: methyldopa sesquihydrate 141.5mg equivalent to to 125 mg methyldopa anhydrous excipient: citric acid   colloidal silicon dioxide disodium edetate dihydrate ethylcellulose guar gum magnesium stearate opadry yellow oy-8462 purified water sodium starch glycolate - hypertension (mild, moderate or severe).

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

viatris limited - methyldopa sesquihydrate 566mg equivalent to to 500 mg methyldopa anhydrous - tablet - 500 mg - active: methyldopa sesquihydrate 566mg equivalent to to 500 mg methyldopa anhydrous excipient: citric acid   colloidal silicon dioxide disodium edetate dihydrate ethylcellulose guar gum magnesium stearate opadry yellow oy-8462 purified water sodium starch glycolate - hypertension (mild, moderate or severe).

Spojené štáty - angličtina - NLM (National Library of Medicine)

american regent, inc. - methyldopate hydrochloride (unii: 7px435dn5a) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopate hydrochloride 50 mg in 1 ml

Malajzia - angličtina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

eucogen sdn bhd - methyldopa -

Spojené štáty - angličtina - NLM (National Library of Medicine)

chartwell rx, llc - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa is contraindicated in patients: — with active hepatic disease, such as acute hepatitis and active cirrhosis — with liver disorders previously associated with methyldopa therapy ( see warnings ) — with hypersensitivity to any component of these products. — on therapy with monoamine oxidase (mao) inhibitors.

Spojené kráľovstvo - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen pharma ltd - methyldopa (anhydrous) - oral tablet - 250mg

Spojené kráľovstvo - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen pharma ltd - methyldopa (anhydrous) - oral tablet - 500mg

Spojené kráľovstvo - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen pharma ltd - methyldopa (anhydrous) - oral tablet - 125mg

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - hydrochlorothiazide 15mg; methyldopa sesquihydrate 250mg - tablet - 15mg/250mg - active: hydrochlorothiazide 15mg methyldopa sesquihydrate 250mg

Spojené kráľovstvo - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - methyldopa (anhydrous) - oral tablet - 125mg